Alpha Lipoic Acid Improves Outcomes In Patients Receiving Pulsed Radiofrequency for Radicular Pain .
Alpha lipoic acid with pulsed radiofrequency in treatment of chronic lumbosacral radicular pain: A prospective, randomized study
Medicine (Baltimore). 2021 Jun 18;100(24): e26344.One hundred and twenty patients with lumbo-sacral radicular pain were randomized to receive pulsed radiofrequency (PRF) with oral alpha lipoic acid (ALA) (n=60) or radiofrequency ablation alone (n=60). The primary outcome of interest was pain relief utilizing the numerical rating score. Secondary outcomes of interest were the Oswestry Low Back Pain Disability score, the Epworth Sleepiness Scale, patient satisfaction, success rate after treatment and adverse events. There was a significant reduction in pain at 3 and 6 months post procedure in the ALA + PRF group compared to the PRF alone group. The ALA group also demonstrated a significant reduction in disability scores at 6 months and a increased number of patients that had a sustained reduction in pain scores. No differences in adverse events were noted.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics